Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMEREO BIOPHARMA GROUP PLC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MREO - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 264.1M | $ -49.55M | 0 |
| 3/31/2025 | $ 368.88M | $ -47.19M | 0 |
| 12/31/2024 | $ 376.83M | $ -43.25M | 0 |
| 9/30/2024 | $ 636.1M | $ 0 | 0 |
| 6/30/2024 | $ 578.49M | $ -36.89M | 0 |
| 3/31/2024 | $ 444.66M | $ 0 | 0 |
| 12/31/2023 | $ 420.82M | $ -29.47M | 0 |
| 6/30/2023 | $ 183.96M | $ -32.59M | 0 |
| 12/31/2022 | $ 94.74M | $ -42.74M | 0 |
| 6/30/2022 | $ 104.46M | $ -23.15M | 0 |
Key Performance Insights, Last 5 Years
- MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average P/E has been 8.24.
- The median P/E for MEREO BIOPHARMA GROUP PLC during this period was 8.24
- MEREO BIOPHARMA GROUP PLC reached its highest P/E over the past 5 years at 8.24.
- The lowest P/E recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe 8.24
MEREO BIOPHARMA GROUP PLC's P/E vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/E Benchmarks
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for MEREO BIOPHARMA GROUP PLC is calculated as follows: Market Cap [ $ 228.45M ] / Net Inc. Cmn. [ $ -204.53M ]
(=) P/E [ 0 ] MREO - Price to Earnings, Last 5 years
8.24
Minimum
Dec 31, 2021
8.24
Maximum
Dec 31, 2021
8.24
Average
8.24
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.52 with a standard deviation of 13.96.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.08K |
|---|---|
| min | 0.13 |
| max | 70.11 |
| average | 22.52 |
| median | 18.89 |
| std | 13.96 |